跳至主要内容
临床试验/NL-OMON20229
NL-OMON20229招募中不适用

Patient reported outcomes in high risk and advanced melanoma patients

one, investigator initiated0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Adults of 18 years and older; Melanoma patients indicated to receive treatment with immune checkpoint-inhibitors, according to the clinical guidelines; Written informed consent to participate in the study.

排除标准

  • Insufficient understanding of the Dutch or English language; Inclusion in experimental clinical trials

研究者

发起方
one, investigator initiated

相似试验